SEPTIN9 and colorectal carcinoma: Considering all CRC cases, SEPT9 promoter methylation levels independently predicted for better DSS [Hazard Ratio (HR) = 0.673, 95% Confidence Interval (CI) 0.469–0.965] while age 60 years or higher and stage IV independently predicted for worse DSS (HR = 1.476, 95% CI 1.085–2.008 and HR = 1.862, 95% CI 1.295–2.677, respectively).